Literature DB >> 30927712

Nef-mediated inhibition of NFAT following TCR stimulation differs between HIV-1 subtypes.

Lisa Naidoo1, Zinhle Mzobe1, Steven W Jin2, Erasha Rajkoomar1, Tarylee Reddy3, Mark A Brockman4, Zabrina L Brumme5, Thumbi Ndung'u6, Jaclyn K Mann7.   

Abstract

Functional characterisation of different HIV-1 subtypes may improve understanding of viral pathogenesis and spread. Here, we evaluated the ability of 345 unique HIV-1 Nef clones representing subtypes A, B, C and D to inhibit NFAT signalling following TCR stimulation. The contribution of this Nef function to disease progression was also assessed in 211 additional Nef clones isolated from unique subtype C infected individuals in early or chronic infection. On average, subtype A and C Nef clones exhibited significantly lower ability to inhibit TCR-mediated NFAT signalling compared to subtype B and D Nef clones. While this observation corroborates accumulating evidence supporting relative attenuation of subtypes A and C that may paradoxically contribute to their increased global prevalence and spread, no significant correlations between Nef-mediated NFAT inhibition activity and clinical markers of HIV-1 infection were observed, indicating that the relationship between Nef function and pathogenesis is complex.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIV-1 Nef; HIV-1 disease progression; HIV-1 subtype C; HLA-associated polymorphisms; Immune-driven escape mutations; NFAT inhibition; TCR signalling

Mesh:

Substances:

Year:  2019        PMID: 30927712      PMCID: PMC6526282          DOI: 10.1016/j.virol.2019.02.011

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  70 in total

1.  A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.

Authors:  Stéphane Guindon; Olivier Gascuel
Journal:  Syst Biol       Date:  2003-10       Impact factor: 15.683

2.  Changes in the distribution of HIV type 1 subtypes D and A in Rakai District, Uganda between 1994 and 2002.

Authors:  Samantha A Conroy; Oliver Laeyendecker; Andrew D Redd; Aleisha Collinson-Streng; Xiangrong Kong; Fredrick Makumbi; Tom Lutalo; Nelson Sewankambo; Noah Kiwanuka; Ronald H Gray; Maria J Wawer; David Serwadda; Thomas C Quinn
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-06       Impact factor: 2.205

3.  Gene expression profiling reveals Nef induced deregulation of lipid metabolism in HIV-1 infected T cells.

Authors:  Surya Shrivastava; Jay Trivedi; Debashis Mitra
Journal:  Biochem Biophys Res Commun       Date:  2016-02-23       Impact factor: 3.575

4.  Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.

Authors:  Philippa J Easterbrook; Mel Smith; Jane Mullen; Siobhan O'Shea; Ian Chrystie; Annemiek de Ruiter; Iain D Tatt; Anna Maria Geretti; Mark Zuckerman
Journal:  J Int AIDS Soc       Date:  2010-02-03       Impact factor: 5.396

5.  Genetic and functional analysis of HIV type 1 nef gene derived from long-term nonprogressor children: association of attenuated variants with slow progression to pediatric AIDS.

Authors:  Guillermo Corró; Carlos A Rocco; Cristian De Candia; Gabriel Catano; Gabriela Turk; Andrea Mangano; Paula C Aulicino; Rosa Bologna; Luisa Sen
Journal:  AIDS Res Hum Retroviruses       Date:  2012-06-25       Impact factor: 2.205

6.  Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.

Authors:  O Schwartz; V Maréchal; S Le Gall; F Lemonnier; J M Heard
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

7.  Effect of HIV-1 subtypes on disease progression in rural Uganda: a prospective clinical cohort study.

Authors:  Deogratius Ssemwanga; Rebecca N Nsubuga; Billy N Mayanja; Frederick Lyagoba; Brian Magambo; Dave Yirrell; Lieve Van der Paal; Heiner Grosskurth; Pontiano Kaleebu
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

Review 8.  HIV-1 Nef: at the crossroads.

Authors:  John L Foster; J Victor Garcia
Journal:  Retrovirology       Date:  2008-09-22       Impact factor: 4.602

9.  In vivo analysis of highly conserved Nef activities in HIV-1 replication and pathogenesis.

Authors:  Richard L Watkins; Wei Zou; Paul W Denton; John F Krisko; John L Foster; J Victor Garcia
Journal:  Retrovirology       Date:  2013-10-30       Impact factor: 4.602

10.  Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes.

Authors:  Jaclyn K Mann; Helen Byakwaga; Xiaomei T Kuang; Anh Q Le; Chanson J Brumme; Philip Mwimanzi; Saleha Omarjee; Eric Martin; Guinevere Q Lee; Bemuluyigza Baraki; Ryan Danroth; Rosemary McCloskey; Conrad Muzoora; David R Bangsberg; Peter W Hunt; Philip J R Goulder; Bruce D Walker; P Richard Harrigan; Jeff N Martin; Thumbi Ndung'u; Mark A Brockman; Zabrina L Brumme
Journal:  Retrovirology       Date:  2013-09-16       Impact factor: 4.602

View more
  5 in total

1.  Tight-Binding Hydroxypyrazole HIV-1 Nef Inhibitors Suppress Viral Replication in Donor Mononuclear Cells and Reverse Nef-Mediated MHC-I Downregulation.

Authors:  Haibin Shi; Colin M Tice; Lori Emert-Sedlak; Li Chen; Wing Fai Li; Marianne Carlsen; Jay E Wrobel; Allen B Reitz; Thomas E Smithgall
Journal:  ACS Infect Dis       Date:  2019-12-16       Impact factor: 5.084

2.  Lentiviral Nef Proteins Differentially Govern the Establishment of Viral Latency.

Authors:  Eric Carlin; Braxton Greer; Kelsey Lowman; Alexander G Dalecki; Alexandra Duverger; Frederic Wagner; Olaf Kutsch
Journal:  J Virol       Date:  2022-03-10       Impact factor: 6.549

3.  Modelling and in vitro testing of the HIV-1 Nef fitness landscape.

Authors:  John P Barton; Erasha Rajkoomar; Jaclyn K Mann; Dariusz K Murakowski; Mako Toyoda; Macdonald Mahiti; Phillip Mwimanzi; Takamasa Ueno; Arup K Chakraborty; Thumbi Ndung'u
Journal:  Virus Evol       Date:  2019-08-05

Review 4.  HIV-1 Latency and Latency Reversal: Does Subtype Matter?

Authors:  Indra Sarabia; Alberto Bosque
Journal:  Viruses       Date:  2019-11-28       Impact factor: 5.048

5.  HIV-1 molecular diversity in Brazil unveiled by 10 years of sampling by the national genotyping network.

Authors:  Tiago Gräf; Gonzalo Bello; Paula Andrade; Ighor Arantes; João Marcos Pereira; Alexandre Bonfim Pinheiro da Silva; Rafael V Veiga; Diana Mariani; Lídia Theodoro Boullosa; Mônica B Arruda; José Carlos Couto Fernandez; Ann M Dennis; David A Rasmussen; Amilcar Tanuri
Journal:  Sci Rep       Date:  2021-08-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.